Position in ABBV
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$7,549
+$1,025 QoQ
Shares Held
30
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4,131
of 4,152 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Bare Financial Services, Inc holds $354,393 across 11 Drug Manufacturers - General names. ABBV ranks #7 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
1,030 | $132,354 | |
| 2 | LLY |
ELI LILLY & Co
|
93 | $111,546 | |
| 3 | AMGN |
Amgen Inc
|
96 | $34,762 | |
| 4 | PFE |
Pfizer Inc
|
1,013 | $24,393 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
186 | $23,498 | |
| 6 | JNJ |
Johnson & Johnson
|
43 | $10,920 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
30 | $7,549 | |
| 8 | BIIB |
Biogen Inc.
|
22 | $4,753 |
All Filings in ABBV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,549 | 30 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $6,524 | 30 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $24,219 | 106 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $26,625 | 115 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $15,220 | 82 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,933 | 14 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||